Professor | Andrew Stephen Lee | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Andrew Stephen Lee
Contact Information	alee@pkusz.edu.cn
Language ability	English, Chinese
Province	Guangdong

Upload Avatar (500 x 500)

Name

Andrew Stephen Lee

Contact Information

alee@pkusz.edu.cn

Language ability

English, Chinese

Province

Guangdong

University/Lab Affiliation and Title	Peking University
Faculty	College of Chemical Biology and Biotechnology
Academic Background & Achievements	Bachelor's Degree: Yale University MD and PhD: Stanford University Published over 60 papers on cell/gene therapy Cited over 9,000 times with an H-index of 40
Work Experience	Current - Peking University Shenzhen Graduate School - Associate Professor Current - Shenzhen Bay Laboratory - Joint Position
Awards	Supported by American Heart Association Supported by Howard Hughes Medical Institute Supported by top 10 global pharmaceutical companies

University/Lab Affiliation and Title

Peking University

Faculty

College of Chemical Biology and Biotechnology

Academic Background & Achievements

Bachelor's Degree: Yale University
MD and PhD: Stanford University
Published over 60 papers on cell/gene therapy
Cited over 9,000 times with an H-index of 40

Work Experience

Current - Peking University Shenzhen Graduate School - Associate Professor
Current - Shenzhen Bay Laboratory - Joint Position

Awards

Supported by American Heart Association
Supported by Howard Hughes Medical Institute
Supported by top 10 global pharmaceutical companies

Areas of Focus	Cell/Gene Therapy Clinical Pathology
Publications	Dual targeted extracellular vesicles regulate oncogenic genes in advances pancreatic cancer., Chiang CL, Ma Y, Hou YC, Pan J, Chen SY, Chien MH, Zhang ZX, Hsu WH, Wang X, Zhang J, Li H, Sun L, Fallen S, Lee I, Chen XY, Chu YS, Zhang X, Cheng TS, Jiang W, Kim BYS, Reategui E, Lee R, Yuan Y, Liu HC, Wang K, Hsiao M, Huang CYF#, Shan YS#, Lee AS#, Lee LJ#., 2023 Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy., You Y, Tian Y, Yang Z, Shi J, Kwak KJ, Estania AP, Tong Y, Cao J, Chiang CL, Hsu WH, Liu Y, Shrank B, Huntoon K, lee D, Li Z, Zhao Y, Zhang H, Gallup T, Ha J, Dong S, Lu WJ, Bahrani E, Lee LJ, Teng L, Jiang W, Lan F#, Kim BYS#, Lee AS#., 2023 Combination of distinct vascular stem / progenitor cells for neovascularization and ischemic rescue., Zhao L, Lee AS, Sasagawa K, Sokol J, Wang Y, Ransom RC, Zhao X, Ma C, Steininger HM, Koepke LS, Borrelli MR, Brewer RE, Lee LLY, Huang X, Ambrosi TH, Sinha R, Hoover MY, Seita J, Weissman IL, Wu JC, Wan DC, Xiao J, Longaker MT, Nguyen PK, Chan CKF., 2023 MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling., Li X, Lu WJ, Li Y, Wu F, Bai R, Na S, Dong T, Zhang H, Lee AS#, Wang Y#, Lan F#., 2019 A novel slow release collagen matrix cross-linked with pro-survival factor analogs promotes stem cell survival for treatment of ischemic cardiovascular disease., Lee AS, Inayathullah M, Lijkwan M, Zhao X, Sun W, Park S, Hong WX, Parekh M, Malkovskiy, Lau E, Qin X, Pothineni V, Sanchez-Freire V, Zhang W, Kooreman N, Ebert A, Chan C, Nguyen PK, Rajadas J, Wu JC., 2018

Areas of Focus

Cell/Gene Therapy
Clinical Pathology

Publications

Dual targeted extracellular vesicles regulate oncogenic genes in advances pancreatic cancer., Chiang CL, Ma Y, Hou YC, Pan J, Chen SY, Chien MH, Zhang ZX, Hsu WH, Wang X, Zhang J, Li H, Sun L, Fallen S, Lee I, Chen XY, Chu YS, Zhang X, Cheng TS, Jiang W, Kim BYS, Reategui E, Lee R, Yuan Y, Liu HC, Wang K, Hsiao M, Huang CYF#, Shan YS#, Lee AS#, Lee LJ#., 2023
Intradermally delivered mRNA-encapsulating extracellular vesicles for collagen-replacement therapy., You Y, Tian Y, Yang Z, Shi J, Kwak KJ, Estania AP, Tong Y, Cao J, Chiang CL, Hsu WH, Liu Y, Shrank B, Huntoon K, lee D, Li Z, Zhao Y, Zhang H, Gallup T, Ha J, Dong S, Lu WJ, Bahrani E, Lee LJ, Teng L, Jiang W, Lan F#, Kim BYS#, Lee AS#., 2023
Combination of distinct vascular stem / progenitor cells for neovascularization and ischemic rescue., Zhao L*, Lee AS*, Sasagawa K*, Sokol J, Wang Y, Ransom RC, Zhao X, Ma C, Steininger HM, Koepke LS, Borrelli MR, Brewer RE, Lee LLY, Huang X, Ambrosi TH, Sinha R, Hoover MY, Seita J, Weissman IL, Wu JC, Wan DC, Xiao J, Longaker MT, Nguyen PK, Chan CKF., 2023
MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling., Li X, Lu WJ, Li Y, Wu F, Bai R, Na S, Dong T, Zhang H, Lee AS#, Wang Y#, Lan F#., 2019
A novel slow release collagen matrix cross-linked with pro-survival factor analogs promotes stem cell survival for treatment of ischemic cardiovascular disease., Lee AS*, Inayathullah M*, Lijkwan M*, Zhao X, Sun W, Park S, Hong WX, Parekh M, Malkovskiy, Lau E, Qin X, Pothineni V, Sanchez-Freire V, Zhang W, Kooreman N, Ebert A, Chan C, Nguyen PK, Rajadas J, Wu JC., 2018

Cell Therapy Gene Therapy Clinical Trials Oncology Stem Cells Biotechnology Regenerative Medicine Molecular Biology Genomics Therapeutics

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us